Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nivolumab Plus Relatlimab in Advanced or Metastatic Soft-tissue Sarcoma
NCT04095208Phase 2Completed
- Sponsor
- Institut Bergonié
- Start
- Feb 2020
- Primary completion
- Sep 2024
- Modality
- Immune Checkpoint Inhibitors
- Countries
- 1
01
Overview
A Phase 2 trial of relatlimab in soft tissue sarcoma (STS), sponsored by Institut Bergonié. Started Feb 2020; status: completed.
02
Drugs
relatlimab
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT04095208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04095208.